Novavax   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Gaithersburg MD United States (1999)

Organization Overview

First Clinical Trial
2007
NCT00519389
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Novavax | Novavax Inc | Novavax, Inc.